Cagrilintide vs Dulaglutide

Cagrilintide is an experimental long-acting amylin drug still in development, while dulaglutide (sold as Trulicity) is an FDA-approved GLP-1 receptor agonist. Dulaglutide is approved to treat type 2 diabetes and reduce cardiovascular risk, whereas cagrilintide has no approved uses yet. The main practical difference is that dulaglutide is already on the market as an injection, while cagrilintide remains in clinical trials.

AI summary of the sources below.